IBS following gastroenteritis may last 4+ years in around half of those affected

Aggressive and pro-inflammatory bacteria and COVID-19 virus possible culprits Irritable bowel syndrome (IBS)---characterised by abdominal pain, bloating, and altered bowel habit—may last 4 or more years following a bout of gastroenteritis in around half of those affected, finds a pooled data analysis of the available evidence, published online in the ...

2024-07-17T15:16:53+00:0017 July 2024|Gut, Press release|

Resistance exercise ‘activity breaks’ at night may improve sleep length

3-minute breaks every half hour for 4 hours may be all that’s needed, small study suggests May be worth reviewing current recommendations which discourage exercise before bed Resistance exercise ‘activity breaks’ at night may improve sleep length, suggest the findings of a small comparative study published in the open access ...

Few UK people likely to be suitable for new Alzheimer’s drugs when they come on stream

But many people with memory loss nevertheless likely to be referred for these treatments Few people in the UK with early stage Alzheimer’s disease are likely to be suitable for the latest drugs which aim to halt progress of the condition, yet many are nevertheless likely to be referred for ...

Rise in global number of patient harms from 11 million to 18 million (59%) in 30 years

Outpacing 45% increase in world’s population during the same period (1990-2019) Older people worldwide bear the brunt, with steepest rise among 65-69 year olds  The proportion of patient harms associated with medical procedures, treatment, and contact with healthcare systems rose by 59%, from 11 million to 18 million globally between ...

2024-07-31T17:40:28+00:0012 July 2024|BMJ Quality & Safety, Press release|

NHS’s relentless focus on finance and productivity is failing patient safety

Patients’ concerns too often go ignored, says England’s first patient safety commissioner “The NHS’s relentless focus on finance and productivity is failing patient safety,” argues patient safety commissioner Henrietta Hughes in an interview for The BMJ today. “The patient’s anecdote is the canary in the coal mine,” she says. It’s the thing ...

2024-08-01T08:51:20+00:009 July 2024|Press release, The BMJ|

Intensive voice treatment more effective than NHS speech therapy for Parkinson’s disease

Results highlight need to optimise speech therapy resources, say researchers An intensive voice treatment developed in the USA and known as the Lee Silverman voice treatment (LSVT LOUD) is more effective than conventional NHS speech and language therapy or no therapy for people with Parkinson’s disease, finds a trial published ...

2024-08-01T08:49:31+00:009 July 2024|Press release, The BMJ|
Go to Top